Brain Tumor Funders’ Collaborative Announces $3 Million in Grants

January 16, 2019

ST. LOUIS--(BUSINESS WIRE)--Jan 16, 2019--The Brain Tumor Funders’ Collaborative (BTFC) – six private funders of brain tumor research – today announced $3 million in grants to four multi-institutional teams of researchers and clinicians studying immunotherapy in primary brain tumors.

“Our goal is to promote the rapid translation of scientific discoveries into effective new treatments for brain cancer patients,” said Susan M. Fitzpatrick, Ph.D., president, James S. McDonnell Foundation, one of the BTFC partners. “By working together, we can provide a higher level of support for advancing the frontiers of brain tumor research.”

The four funded projects will examine vaccination strategies, the tumor’s micro-environment, anti-tumor T-cells, and personalized immunotherapy approaches. They were selected during a multi-stage review process from more than 79 responses to the BTFC call for proposals.

The following institutions will be receiving $750,000 BTFC grants over the next three years:

Project Sponsor: David Geffen School of Medicine at UCLA Project Title: Active vaccination and the timing of checkpoint blockade dictate effective immunotherapy for glioblastoma Project Manager: Robert Prins

Project Sponsor: McGill University Project Title: Harnessing the brain tumor immune-microenvironment to enhance therapeutic efficacy Project Manager: Daniela Quail

Project Sponsor: UPMC Children’s Hospital of Pittsburgh Project Title: Interrogating anti-tumor T-cells To develop adoptive cell transfer (ACT) Immunotherapy for pediatric high-grade gliomas Project Manager: Gary Kohanbash

Sponsoring Institution: University of California, San Francisco Project Title: Three dimensional immuno-genomics approach to personalized neoantigen-based immunotherapy Project Manager: Joseph Costello

The Brain Tumor Funders Collaborative was formed by private foundations and non-profit organizations to pool their resources and become more strategic by focusing their research dollars toward specific therapeutic goals. The BTFC organizations combine this research funding with patient education and advocacy.

Note: The following organizations participate in the BTFC and in this joint funding initiative:

American Brain Tumor Association (ABTA) Brain Tumour Foundation of Canada James S. McDonnell Foundation Pediatric Brain Tumor Foundation Sontag Foundation Anonymous

Further information about the BTFC and its funding initiative can be found at www.braintumorfunders.org.

Brain tumor facts are available at https://seer.cancer.gov/statfacts/html/brain.html

View source version on businesswire.com:https://www.businesswire.com/news/home/20190116005080/en/

CONTACT: Susan M. Fitzpatrick, Ph.D

James S. McDonnell Foundation

Tel: 314-721-1532

Email:susan@jsmf.org

KEYWORD: UNITED STATES NORTH AMERICA MISSOURI

INDUSTRY KEYWORD: OTHER CONSUMER HEALTH ONCOLOGY PHILANTHROPY OTHER SCIENCE OTHER PHILANTHROPY CONSUMER SCIENCE FOUNDATION FUND RAISING GENERAL HEALTH

SOURCE: Brain Tumor Funders’ Collaborative

PUB: 01/16/2019 10:30 AM/DISC: 01/16/2019 10:30 AM

http://www.businesswire.com/news/home/20190116005080/en